Task force guidelines handbook: EFNS guidelines on diagnosis and management of fatty acid mitochondrial disorders

European Journal of Neurology

Volumn 13, Issue 9, 2006, Pages 923-929

  Angelini, C ^a   Federico, A ^b   Reichmann, H ^c   Lombes, A ^d   Chinnery, P ^e   Turnbull, D ^e  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

oxidation mitochondria; Acyl CoA dehydrogenase; Carnitine; Carnitine palmitoyltransferase; Long chain fatty acid

Indexed keywords

ARTICLE; CARBOHYDRATE DIET; CARDIOMYOPATHY; DIAGNOSTIC TEST; ENERGY RESOURCE; ENZYME DEFICIENCY; EVIDENCE BASED MEDICINE; HUMAN; HYPOGLYCEMIA; INFORMATION PROCESSING; LIPIDOSIS; OXIDATION; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SUDDEN DEATH;

ADVISORY COMMITTEES; EUROPE; FATTY ACIDS; HUMANS; MITOCHONDRIAL DISEASES; NEUROLOGY; PRACTICE GUIDELINES; SOCIETIES, MEDICAL;

EID: 33747864871     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01482.x     Document Type: Article

References (23)

1. Vockley J, Whiteman DA. Defects of mitochondrial betaoxidation: a growing group of disorders. Neuromuscular Disorders 2002; 12: 235-246.
2. Angelini C, Vergani L, Martinuzzi A. Clinical and biochemical aspects of carnitine deficiency and insufficiency: transport defects and inborn errors of beta-oxidation. Critical Reviews in Clinical Laboratory Sciences 1992; 29: 217-242.
3. Brainin M, Barnes M, Baron JC, et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004. European Journal of Neurology 2004; 11: 577-581.
4. Orngreen MC, Duno M, Ejstrup R, et al. Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations. Annals of Neurology 2005; 57: 60-66.
5. Better OS, Stein GH. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolisis. The New England Journal of Medicine 1990; 322: 825-829.
6. Tein L, De Vivo C, Brieman F, et al. Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Paediatric Research 1990; 28: 247-255.
7. Nezu J, Tamai I, Oku A, et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nature Genetics 1999; 21: 91-94.
8. Chapoy PR, Angelini C, Brown WJ, Stiff J, Shug AL, Cederbaum SD. Systemic carnitine deficiency: a treatable inherited lipid storage disease presenting as recurrent Reye's syndrome. The New England Journal of Medicine 1980; 303: 1389-1394.
9. Tang NL, Ganapathy V, Wu X, et al. Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency. Human Molecular Genetics 1999; 8: 655-660.
10. Wang Y, Taroni F, Garavaglia B, Longo N. Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation. Human Mutation 2000; 16: 401-407.
11. Engel AG, Angelini C. Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: reports of a new syndrome. Science 1973; 179: 899-902.
12. Vergani L, Angelini C. Infantile lipid storage myopathy with nocturnal hypoventilation shows abnormal low-affinity muscle carnitine uptake in vitro. Neuromuscular Disorders 1999; 5: 320-322.
13. Hale DE, Batshaw MC, Coates P, et al. Long-chain acyl-Coenzyme A dehydrogenase deficiency: an inherited cause of no ketotic hypoglicaemia. Paediatric Research 1985; 19: 666-671.
14. Olgivie I, Pourfarzam M, Jackons S, et al. Very long-chain acyl-Coenzyme A dehydrogenase deficiency presenting with exercise induced myoglobinuria. Neurology 1994; 44: 463-473.
15. Orngreen MC, Norgaard MG, Sacchetti M, van Engelen BG, Vissing J. Fuel utilization in patients with very long-chain acyl-CoA dehydrogenase deficiency. Annals of Neurology 2004; 56: 279-283.
16. Schaefer J, Jackson S, Dick DJ, Turnbull DM. Trifunctional enzyme deficiency: adult presentation of a usually fatal beta-oxidation defect. Annals of Neurology 1996; 40: 597-602.
17. Ziadeh R, Hoffman EP, Finegold DN, et al. Medium-chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies. Paediatric Research 1995; 37: 675-678.
18. Coates PM, Acili DE, Finocchiaro G, Tanaka K, Winter SC. Genetic deficiency of short chain acyl-Coenzyme A dehydrogenase in cultured fibroblasts from a patient with muscle carnitine deficiency and severe skeletal muscle weakness. Journal of Clinical Investigation 1988; 81: 171-175.
19. Antozzi C, Garavaglia B, Mora M, et al. Late-onset riboflavin responsive myopathy with combined multiple acyl-CoA dehydrogenase and respiratory chain deficiency. Neurology 1994; 44: 2153-2158.
20. Vergani L, Angelini C, Pegoraro E, et al. Hereditary protein C deficiency associated with riboflavin responsive lipid storage myopathy. European Journal of Neurology 1996; 3: 61-65.
21. Vergani L, Barile M, Angelini C, et al. Riboflavin therapy: biochemical heterogeneity in two adult lipid storage myopathies. Brain 1999; 122: 2401-2411.
22. Orngreen MC, Ejstrup R, Vissing J. Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency. Neurology 2003; 61: 559-561.
23. Roe CR, Sweetman L, Roe DS, David F, Brunengraber H. Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. Journal of Clinical Investigation 2002; 110: 259-269.